Infant botulism in Singapore
Singapore Med J
.
2020 Mar;61(3):165-166.
doi: 10.11622/smedj.2020017.
Authors
Natasha Charan
1
,
Ju-Ming Judith Wong
2
,
Wei Shih Derrick Chan
3
,
Zheng Jie Marc Ho
4
,
Heng Chiak James Sim
5
6
,
Jin Phang Loh
7
,
Ling Yann Foo
7
8
,
Sophie Octavia
9
,
Michelle Ang
9
,
Koh Cheng Thoon
10
Affiliations
1
Department of Paediatrics, KK Women's and Children's Hospital, Singapore.
2
Children's Intensive Care Unit, KK Women's and Children's Hospital, Singapore.
3
Paediatric Neurology, KK Women's and Children's Hospital, Singapore.
4
Communicable Diseases Division, Ministry of Health, Singapore.
5
Department of Microbiology, Singapore General Hospital, Singapore.
6
Duke-NUS Medical School, Singapore.
7
Biological Defence Programme, DSO National Laboratories, Singapore.
8
Chemical, Toxins, Radiological and Nuclear Defence Programme, DSO National Laboratories, Singapore.
9
National Public Health Laboratory, Ministry of Health, Singapore.
10
Paediatric Infectious Disease, KK Women's and Children's Hospital, Singapore.
PMID:
32488271
PMCID:
PMC7905118
DOI:
10.11622/smedj.2020017
No abstract available
Publication types
Case Reports
MeSH terms
Botulism / therapy*
Humans
Immunoglobulins / therapeutic use*
Infant
Male
Singapore
Substances
Immunoglobulins
botulism immune globulin